BB-301 — FDA meeting
2026
Benitec plans to meet with the FDA in 2026 to confirm the BB-301 pivotal study designSource filing
BENITEC BIOPHARMA INC · Data as of 2026-09-08
2026
Benitec plans to meet with the FDA in 2026 to confirm the BB-301 pivotal study designSource filing
2H-2026
Benitec remains on track to provide updated interim clinical study results in 2H-2026Source filing